Litcius/Paper detail

Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways

Chong Zhang, Lili Li, Shu Hou, Zhenghao Shi, Wenjing Xu, Qin Wang, Yinghao He, Yongfang Gong, Zhirui Fang, Yan Yang

2021Journal of Ethnopharmacology51 citationsDOI

Topics & Concepts

Hepatocellular carcinomaCancer researchLiver cancerMedicineCancerBlotMetastasisIn vivoApoptosisPathologyPharmacologyBiologyInternal medicineBiochemistryBiotechnologyGeneTGF-β signaling in diseasesTraditional Chinese Medicine AnalysisNF-κB Signaling Pathways
Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways | Litcius